Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAN06: Dymista for Asthmatic Inflammation
NCT02953106Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- Jan 2017
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of azelastine + fluticasone in asthma and allergic rhinitis (AR), sponsored by University of Dundee. Started Jan 2017; status: terminated.
02
Drugs
azelastine + fluticasone
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02953106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953106.